Working to Eradicate Gynecologic Cancers

188
Adding a molecular profile test to make use of bevacizumab more affordable in ovarian cancer

Saturday, March 28, 2015: 9:55 AM
Salon C-D (Hilton Chicago)
J. P. Geisler1, A. Walter2 and K. J. Manahan1
1Georgia Regents University/University of Georgia Medical Partnership, Athens, GA, 2The University of Oklahoma, Stephenson Cancer Center, Oklahoma City, OK